Analysis of the data revealed that CPN1 over-expression could be consistently linked to adverse clinicopathological features such as lymph node metastasis and the pathological stage (pTNM) (P < 0.05). This evidence concerns the gene CPN1 and metastatic malignant neoplasm in the lymph nodes.